Published in J Clin Invest on March 01, 1997
What can we learn from rodents about prolactin in humans? Endocr Rev (2007) 2.38
Wnt5 signaling in vertebrate pancreas development. BMC Biol (2005) 1.45
Prolactin receptor signaling is essential for perinatal brown adipocyte function: a role for insulin-like growth factor-2. PLoS One (2008) 1.02
New insights in prolactin: pathological implications. Nat Rev Endocrinol (2015) 0.98
Differential and complementary effects of glucose and prolactin on islet DNA synthesis and gene expression. Endocrinology (2011) 0.85
Defective prolactin signaling impairs pancreatic β-cell development during the perinatal period. Am J Physiol Endocrinol Metab (2013) 0.83
Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells. Diabetes (2016) 0.81
Regulation of islet beta-cell pyruvate metabolism: interactions of prolactin, glucose, and dexamethasone. Endocrinology (2010) 0.81
MafA is required for postnatal proliferation of pancreatic β-cells. PLoS One (2014) 0.79
Influence of estradiol and fetal stress on luteinizing hormone, follicle-stimulating hormone, and prolactin in late-gestation fetal sheep. Neonatology (2011) 0.79
Prolactin mediates effects of chronic psychological stress on induction of fibrofatty cells in the heart. Am J Transl Res (2016) 0.75
Prolactin rs1341239 T allele may have protective role against the brick tea type skeletal fluorosis. PLoS One (2017) 0.75
Association between serum prolactin levels and insulin resistance in non-diabetic men. PLoS One (2017) 0.75
Serum Prolactin and Cardiac Remodeling in Subjects with Prediabetes. Diabetes Metab J (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Developmental patterns of insulin-like growth factor-I and -II synthesis and regulation in rat fibroblasts. Nature (1983) 1.51
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol (1989) 1.48
Induction of alveolar type II cell differentiation in fetal tracheal epithelium by grafted distal lung mesenchyme. Dev Biol (1994) 1.36
On the origin of pancreatic endocrine cells. Cell (1988) 1.29
Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. Endocrinology (1995) 1.08
Regulation of the primate fetal adrenal cortex. Endocr Rev (1990) 1.05
Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. J Biol Chem (1994) 1.04
Pregnancy and the prolactin family of hormones: coordination of anterior pituitary, uterine, and placental expression. Endocr Rev (1991) 1.01
Prolactins of pregnancy and their cellular source. Int Rev Cytol (1988) 1.00
The prolactin receptor in the fetal rat: cellular localization of messenger ribonucleic acid, immunoreactive protein, and ligand-binding activity and induction of expression in late gestation. Endocrinology (1995) 0.99
Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen. J Biol Chem (1991) 0.94
Characterization and applications of monoclonal antibodies to the prolactin receptor. Endocrinology (1989) 0.94
Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17 alpha-hydroxylase/17, 20-lyase, and 3 beta-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab (1993) 0.93
Pregnancy lactogens in the rat conceptus and fetus: circulating levels, distribution of binding, and expression of receptor messenger ribonucleic acid. Endocrinology (1993) 0.92
Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland. J Clin Endocrinol Metab (1996) 0.91
Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets. Endocrinology (1996) 0.91
Incorporation of [3H]thymidine by isolated fetal myoblasts and fibroblasts in response to human placental lactogen (HPL): possible mediation of HPL action by release of immunoreactive SM-C. J Cell Physiol (1985) 0.90
The ontogenesis of human fetal hormones. I. Growth hormone and insulin. J Clin Invest (1972) 0.89
Placental lactogen and growth hormone receptors in human fetal tissues: relationship to fetal plasma human placental lactogen concentrations and fetal growth. J Clin Endocrinol Metab (1988) 0.89
Multihormonal regulation of surfactant synthesis by human fetal lung in vitro. J Clin Endocrinol Metab (1981) 0.87
1,25-dihydroxyvitamin D3 receptors in rat lung during the perinatal period: regulation and immunohistochemical localization. Endocrinology (1990) 0.85
Ontogeny of growth hormone and prolactin gene expression in mice. Endocrinology (1982) 0.85
Concentrations of placental lactogen in chronically catheterized ewes and fetuses in late pregnancy. J Endocrinol (1980) 0.84
Morphogenesis and histogenesis of the connecting tubule in the rat kidney. Anat Embryol (Berl) (1982) 0.84
Regulation of amino acid uptake and deoxyribonucleic acid synthesis in isolated human fetal fibroblasts and myoblasts: effect of human placental lactogen, somatomedin-C, multiplication-stimulating activity, and insulin. J Clin Endocrinol Metab (1986) 0.84
Prolactin and epidermal growth factor regulation of the proliferation, morphogenesis, and functional differentiation of normal rat mammary epithelial cells in three dimensional primary culture. J Cell Physiol (1995) 0.83
Ontogenesis of prolactin receptor gene expression in the rat olfactory system: potential roles for lactogenic hormones in olfactory development. Endocrinology (1996) 0.82
Binding of prolactin by fetal rhesus cell membrane fractions. Endocrinology (1977) 0.81
Cellular distribution of prolactin receptors in human digestive tissues. J Clin Endocrinol Metab (1996) 0.81
Functional activity of the human prolactin receptor and its ligands. Mol Cell Endocrinol (1995) 0.79
Postreceptor signalling of growth hormone and prolactin and their effects in the differentiated insulin-secreting cell line, INS-1. Endocrinology (1996) 0.79
Ovine placental lactogen, but not growth hormone, stimulates amino acid transport in fetal rat diaphragm. Endocrinology (1983) 0.79
The presence of lactogen receptors in human chorion laeve. J Clin Endocrinol Metab (1980) 0.78
Gestational profiles of rat placental lactogen-II (rPL-II) and growth hormone (GH) in maternal and fetal serum, amniotic fluid, and placental tissue. Endocrinol Jpn (1991) 0.78
Placental lactogen-binding sites in isolated fetal fibroblasts: characterization, processing, and regulation. Endocrinology (1993) 0.78
Hypothalamic control of prolactin secretion during the perinatal period in the rat. Endocrinology (1984) 0.78
Fetal plasma prolactin levels and fetal growth in relation to maternal CB-154 treatment in the rat. Gen Comp Endocrinol (1979) 0.77
Interactions of prolactin and adrenocorticotropin in the regulation of adrenocortical secretions in female rats. Endocrinology (1979) 0.77
The placental lactogen receptor in maternal and fetal sheep liver: regulation by glucose and role in the pathogenesis of fasting during pregnancy. Endocrinology (1992) 0.77
Prolactin stimulates and potentiates adrenal steroid secretion in vitro. Horm Res (1984) 0.77
The concentration of bovine placental lactogen and the incidence of different forms in fetal cotyledons and in fetal serum. Domest Anim Endocrinol (1987) 0.77
Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev (1998) 3.82
Teaching in accident and emergency medicine: 10 commandments of accident and emergency radiology. BMJ (1995) 3.43
Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev (1997) 3.12
Comparison of multiple-pass 24-hour recall estimates of energy intake with total energy expenditure determined by the doubly labeled water method in young children. J Am Diet Assoc (1996) 3.00
Twisted gastrulation is a conserved extracellular BMP antagonist. Nature (2001) 2.50
A confidential study of deaths after emergency medical admission: issues relating to quality of care. Clin Med (2003) 2.10
ABC of major trauma. Trauma in pregnancy. BMJ (1990) 2.02
Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell (1988) 2.00
Are younger classroom children disproportionately referred for childhood academic and behavior problems? J Consult Clin Psychol (1987) 1.99
Cross-calibration of body-composition techniques against dual-energy X-ray absorptiometry in young children. Am J Clin Nutr (1996) 1.90
An observational survey of emergency department rapid sequence intubation. Emerg Med J (2001) 1.84
Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology (1974) 1.81
Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplant (2008) 1.71
Preventable deaths after injury: why are the traditional 'vital' signs poor indicators of blood loss? J Accid Emerg Med (1995) 1.71
Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol (1999) 1.70
Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol (2001) 1.66
ATLS: past, present, and future. Emerg Med J (2005) 1.59
Radioreceptor assay for prolactin and other lactogenic hormones. Science (1973) 1.56
Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest (2000) 1.54
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol (1993) 1.48
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol (1989) 1.48
Readability of pediatric biomedical research informed consent forms. Pediatrics (1990) 1.43
Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives. Public Health Genomics (2011) 1.40
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology (1994) 1.40
Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci U S A (1991) 1.40
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. Transplantation (1997) 1.39
Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev (1996) 1.38
Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem (1992) 1.35
Disproportionate referrals for child academic/behavior problems: replication and extension. J Consult Clin Psychol (1990) 1.35
Studies of insulin, growth hormone and prolactin binding: ontogenesis, effects of sex and pregnancy. Endocrinology (1974) 1.35
Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab (1998) 1.31
The utility of the Kohlman Evaluation of Living Skills test is associated with substantiated cases of elder self-neglect. J Am Acad Nurse Pract (2007) 1.29
Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis. FEBS Lett (1991) 1.28
Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol (1992) 1.27
Null mutation of the prolactin receptor gene produces a defect in maternal behavior. Endocrinology (1998) 1.27
Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland. Proc Natl Acad Sci U S A (1989) 1.26
Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab (1993) 1.25
Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology (1994) 1.23
Mammary gland development in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia (1997) 1.23
Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. J Biol Chem (1999) 1.22
Evolution of prolactin receptors in rabbit mammary gland during pregnancy and lactation. Endocrinology (1977) 1.21
Induction of a lactogenic receptor in rat liver: influence of estrogen and the pituitary. Proc Natl Acad Sci U S A (1974) 1.18
Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J Biol Chem (1995) 1.18
A role for betaFTZ-F1 in regulating ecdysteroid titers during post-embryonic development in Drosophila melanogaster. Dev Biol (2005) 1.18
Expression of two forms of prolactin receptor in rat ovary and liver. Mol Endocrinol (1990) 1.17
Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem (1994) 1.17
Trauma education. Resuscitation (2001) 1.16
Prolactin receptors in rat liver: possible induction by prolactin. Science (1975) 1.15
Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci U S A (1994) 1.14
Peptide selection by class I molecules of the major histocompatibility complex. Curr Biol (1993) 1.14
Immune system development and function in prolactin receptor-deficient mice. J Immunol (1999) 1.10
Regional changes in brain glucose metabolism reflect cognitive impairments in aged rats. J Neurosci (1984) 1.10
Significant differences in charge times among currently available implantable cardioverter defibrillators. Pacing Clin Electrophysiol (1999) 1.08
Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J Clin Endocrinol Metab (1997) 1.07
The use of short-stay wards. A survey of 1,000 admissions. Health Bull (Edinb) (1987) 1.07
Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation. Bone Marrow Transplant (2008) 1.07
Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. Am J Physiol (1995) 1.06
Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology (2001) 1.05
A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J Biol Chem (1991) 1.05
Temporal manipulation of transferrin-receptor-1-dependent iron uptake identifies a sensitive period in mouse hippocampal neurodevelopment. Hippocampus (2012) 1.05
Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett (1999) 1.05
Telomerase activity and phenotypic characterization in harvested bone marrow from a child with a germline cell cancer. Transplant Proc (1997) 1.05
Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. J Biol Chem (1994) 1.04
Mutational analysis of the ligand-binding domain of the prolactin receptor. J Biol Chem (1991) 1.04
PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation. EMBO J (1996) 1.02
Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol (1993) 1.02
Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology (1999) 1.01
Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol Endocrinol (1996) 1.00
Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity. Clin Transplant (2000) 0.99
Testing the validity of the ATLS classification of hypovolaemic shock. Resuscitation (2010) 0.99
The prolactin receptor in the fetal rat: cellular localization of messenger ribonucleic acid, immunoreactive protein, and ligand-binding activity and induction of expression in late gestation. Endocrinology (1995) 0.99
Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature (1984) 0.99
Craniofacial and intraoral phenotype of Robinow syndrome forms. Clin Genet (2011) 0.99
Emergency oxygen therapy for the COPD patient. Emerg Med J (2001) 0.98
The prolactin/growth hormone receptor family: structure/function relationships. J Mammary Gland Biol Neoplasia (1997) 0.98
Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene (2000) 0.97
Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Selective enhancement by anti-mouse IgG. J Biol Chem (1990) 0.96
Prolactin signaling influences the timing mechanism of the hair follicle: analysis of hair growth cycles in prolactin receptor knockout mice. Endocrinology (2001) 0.96
Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab (1982) 0.96
The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Mol Endocrinol (1997) 0.96
Enduring effects of environmental enrichment on novelty seeking, saccharin and ethanol intake in two rat lines (RHA/Verh and RLA/Verh) differing in incentive-seeking behavior. Pharmacol Biochem Behav (2002) 0.96
Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin. Biochem Biophys Res Commun (1977) 0.95
Rapid sequence induction in the emergency department: a strategy for failure. Emerg Med J (2002) 0.95
Inhibition of nitric oxide synthase does not impair spatial learning. J Neurosci (1994) 0.95
Pre-hospital cardiac arrest: room for improvement. Resuscitation (1995) 0.95
Inhibition of nitric oxide synthase does not prevent the induction of long-term potentiation in vivo. J Neurosci (1994) 0.95
Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration. Endocrinology (2000) 0.94
Identification and functional activity of prolactin receptors in thymic epithelial cells. Proc Natl Acad Sci U S A (1991) 0.94
Characterization and applications of monoclonal antibodies to the prolactin receptor. Endocrinology (1989) 0.94
Dissociation between mesocortical dopamine release and fear-related behaviours in two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions. Eur J Neurosci (2003) 0.94
Biological activities of binding site specific monoclonal antibodies to prolactin receptors of rabbit mammary gland. J Biol Chem (1985) 0.93
A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc Natl Acad Sci U S A (1995) 0.93
Inbred Roman high- and low-avoidance rats: differences in anxiety, novelty-seeking, and shuttlebox behaviors. Physiol Behav (1999) 0.93
Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay. J Biol Chem (1996) 0.93
Pregnancy lactogens in the rat conceptus and fetus: circulating levels, distribution of binding, and expression of receptor messenger ribonucleic acid. Endocrinology (1993) 0.92
Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol Endocrinol (1997) 0.92
Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland. J Clin Endocrinol Metab (1996) 0.91
Grb10 identified as a potential regulator of growth hormone (GH) signaling by cloning of GH receptor target proteins. J Biol Chem (1998) 0.91